Divi's Laboratories Ltd

Divi's Laboratories Ltd

DIVISLAB

 5,916.03
- 58.87
0.99%
Healthcare
 0.00
(%)1D
Updated: 12 Sep 2025, 03:31:23 pm IST
Stock Score
Open Price
 5,928.76
Prev. Close
 5,974.90
 5,893.08
Day Low
 5,974.20
Day High

 4,932.94
52 Week Low
 6,986.75
52 Week High

Quick Bite

Price To Earnings Ratio

71.55

Sector PE

68.10

PB Ratio

10.47

Sector PB

5.99

EPS

82.68

Dividend Yield

0.52

Today's Volume

485.022 K

5 Day Avg. Volume

440.442 K

PEG Ratio

1.94

Market Cap.

₹ 1,60,000.00 Cr.

About Divi's Laboratories Ltd

Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl, Vigabatrin, and others. The Company is also engaged in custom synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with a portfolio of products across diverse therapeutic areas. The Company's subsidiaries include Divis Laboratories (USA) Inc. and Divi's Laboratories Europe AG.

Divi's Laboratories Ltd Share Price

Divi's Laboratories Limited is an Indian company that manufactures and markets active ingredients (APIs), intermediates and nutrients for export. The company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to its generic business, the Company supports pharmaceutical companies through custom synthesis businesses in the commercialization of their proprietary products, from gram-scale requirements for clinical trials to launch and late life cycle management. The company's subsidiaries are Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG.

Divi's Laboratories Ltd FAQs

How to Buy Divi's Laboratories Ltd Share?

up
To purchase Divi's Laboratories Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Divi's Laboratories Ltd (ticker symbol: DIVISLAB) on the trading platform provided by your broker and purchase the shares.

What's Divi's Laboratories Ltd share price today?

up
The stock price of Divi's Laboratories Ltd as of 15 Sep 2025 is ₹5,916.03

What is the Market Cap of Divi's Laboratories Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 15 Sep 2025, Divi's Laboratories Ltd (ticker symbol: DIVISLAB) has a market capitalisation of approximately ₹16,00,00,00,00,000.00

What is the PE and PB ratio of Divi's Laboratories Ltd?

up
Divi's Laboratories Ltd Ltd's price-to-book ratio as of 15 Sep 2025 is 10.47, reflecting the market's valuation compared to its asset value. As of 15 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 71.55, indicating the market values the company at around ₹71.55 for every ₹1 of earnings

What is the 52 Week High and Low of Divi's Laboratories Ltd Share?

up
Divi's Laboratories Ltd Ltd (DIVISLAB) hit its 52-week high at ₹6,986.75, and its 52-week low at ₹4,932.94.
Begin your investment journey today
Login/Register
Start Now